Interleukin-6, a new target for therapy in multiple myeloma?
- 1 May 1993
- journal article
- review article
- Published by Springer Nature in Annals of Hematology
- Vol. 66 (5), 219-223
- https://doi.org/10.1007/bf01738469
Abstract
During the past few years much insight has been gained into the immunobiology of multiple myeloma. It has become evident that the growth of myeloma cells is regulated by cytokines, notably interleukin-6. In this paper a brief review is given of the evidence derived from in vitro as well as in vivo observations that interleukin-6 is involved in the pathogenesis of multiple myeloma, and the implications of these findings for the development of new therapeutic strategies are discussed.Keywords
This publication has 72 references indexed in Scilit:
- Anti‐human interleukin‐6 receptor antibody inhibits human myeloma growth in vivoEuropean Journal of Immunology, 1992
- In vivo interleukin 6 gene expression in the tumoral environment in multiple myelomaEuropean Journal of Immunology, 1991
- Recombinant interferon- γ inhibits the growth of IL-6-dependent human multiple myeloma cell lines in vitroEuropean Journal of Haematology, 1991
- Serum levels of interleukin-6 in multiple myeloma and other hematological disorders: correlation with disease activity and other prognostic parametersAnnals of Hematology, 1991
- Interleukin-6 enhances human Ig production, but not as a terminal differentiation factor for B lymphocytesResearch in Immunology, 1990
- Expression of an exogenous interleukin 6 gene in human Epstein Barr virus B cells confers growth advantage and in vivo tumorigenicity.The Journal of Experimental Medicine, 1990
- The role of interleukin‐1 and tumour necrosis factor‐α in human multiple myelomaBritish Journal of Haematology, 1990
- Establishment of two interleukin 6 (B cell stimulatory factor 2/interferon beta 2)-dependent human bone marrow-derived myeloma cell lines.The Journal of Experimental Medicine, 1989
- Multiple myeloma treated with high dose intravenous melphalanBritish Journal of Haematology, 1987
- Induction of Plasma-Cell Neoplasms in Strain BALB/c Mice with Mineral Oil and Mineral Oil AdjuvantsNature, 1962